Related Experiment Video
Updated: May 6, 2026
08:12
Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
13.5K
Myocardial viability on trial
Leonardo Bolognese1, Matteo Rocco Reccia1
1Cardiovascular Department, Azienda Ospedaliera Toscana Sudest.
Summary
Myocardial viability assessment in ischaemic left ventricular dysfunction (ILVD) is shifting. New evidence challenges the traditional view, suggesting a more comprehensive approach is needed for better patient outcomes.
Area of Science:
- Cardiology
- Medical Imaging
- Clinical Decision-Making
Background:
- Myocardial viability traditionally refers to dysfunctional myocardium expected to recover function post-revascularization.
- The 'viability hypothesis' posits improved outcomes with revascularization based on viability assessment.
- Ischaemic left ventricular dysfunction (ILVD) management relies on assessing myocardial viability.
Purpose of the Study:
- To critically evaluate the traditional paradigm of myocardial viability assessment in ILVD.
- To explore the divergence between retrospective and prospective trial data regarding the viability hypothesis.
- To advocate for a conceptual shift in understanding ILVD and revascularization benefits.
Main Methods:
- Review of retrospective observational studies supporting the viability hypothesis.
- Analysis of data from prospective clinical trials challenging the hypothesis.
- Conceptual analysis of ILVD pathophysiology and revascularization effects.
Main Results:
- Retrospective studies supported the 'viability hypothesis' linking functional recovery to improved outcomes.
- Prospective trial data have challenged the traditional viability hypothesis.
- Binary viability assessment may oversimplify the complexity of ILVD and revascularization.
Conclusions:
- A paradigm shift is required from dichotomous viability assessment to a comprehensive understanding of ILVD.
- Revascularization benefits extend beyond functional recovery, including prevention of myocardial infarction and arrhythmias.
- A nuanced approach is necessary for optimal clinical decision-making in ILVD patients.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
495
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
495
01:30Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
01:29Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
01:29Cardiomyopathy V: Interprofessional Care
753
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753